On the one hand, PPAR gamma can act as a tumor inhibitor in colon cancer [99–105], in breast cancer [106–110], in urological cancer [110–115], in lung cancer [116–118], and in gastric cancer [119–122]. This evidence concerns the gene PPARG and breast carcinoma.